COVIDIV - Collateral damage of the COVID-19 pandemic observed among patients receiving treatment with intravitreal (IVT) injections of antiangiogenic agents

Head :
Mauget-Faÿsse Martine

Last update : 04/21/2021 | Version : 1 | ID : 73553

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Collateral damage of the COVID-19 pandemic observed among patients receiving treatment with intravitreal (IVT) injections of antiangiogenic agents
Sign or acronym COVIDIV
General Aspects
Medical area Ophthalmology
Study in connection with Covid-19 Yes
Pathology (details) Exudative ARMD, diabetes, retinal vein occlusion (RVO), or other disorders causing macular oedema
Scientific investigator(s) (Contact)
Name of the director Mauget-Faÿsse
Surname Martine
Address Hôpital Fondation A. de Rothschild, PIC-CIC, 29 rue Manin 75019 PARIS
Phone 01 48 03 64 37
Organization Foundation A. de Rothschild Hospital
Collaborations
Participation in projects, networks and consortia No
Funding
Governance of the database
Sponsor(s) or organisation(s) responsible Foundation A. de Rothschild Hospital/Clinical Research Unit
Organisation status Both
Presence of scientific or steering committees No
Additional contact
Name of the contact VACHEY
Surname Patrick
Address Hôpital Fondation A. de Rothschild, PIC-CIC, 29 rue Manin 75019 PARIS
Phone 01 48 03 64 33
Email pvachey@for.paris
Organization Hôpital Fondation A. de Rothschild
Name of the contact THEVENIN
Surname Sophie
Address Hôpital Fondation A. de Rothschild, PIC-CIC, 29 rue Manin 75019 PARIS
Phone 01 48 03 65 96
Email sthevenin@for.paris
Organization Hôpital Fondation A. de Rothschild
Main features
Type of database
Type of database Others
Specify Questionnaire at inclusion + follow-up data taken from the medical records
Database recruitment is is made on the basis of: Medication(s) taken
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Patient information following their first visit after the first lockdown on 11/05/2021: Patients contacted by telephone or informed during appointments.
Database objective
Main objective Describe the changes in visual acuity among patients receiving treatment with repeat IVT injections of antiangiogenic agents during the COVID-19 epidemic, between September 2019 and May 2021
Inclusion criteria Patient aged 18 years and over
-Eye disorder requiring treatment with repeat IVT injections of antiangiogenic agents: Exudative ARMD, macular oedema associated with diabetes or secondary to retinal vein occlusion.
-Initiation of treatment with repeat IVT injections before 01/10/2019
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Pathology H35 - Other retinal disorders
Gender Male
Woman
Geography area National
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2020
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 1,500 planned - actual number included: 233
Data
Database activity Current data collection
Type of data collected Clinical data
Declarative data
Clinical data (detail) Direct physical measures
Details of collected clinical data Treatment with IVT injections, outcome of the treated disorder
Declarative data (detail) Phone interview
Details of collected declarative data Questionnaire on visits during the lockdown
Presence of a biobank No
Procedures
Participant monitoring Yes
Details on monitoring of participants Follow-up with data in the medical records up to a year after resuming follow-up after 11/05/2021
Links to administrative sources No
Promotion and access
Promotion
Access

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05